https://sputnikglobe.com/20230110/peer-reviewed-journal-vaccines-confirms-long-term-efficacy-of-russias-sputnik-v-1106203684.html
RDIF: Peer-Reviewed Journal Vaccines Confirms Long-Term Efficacy of Russia's Sputnik V
RDIF: Peer-Reviewed Journal Vaccines Confirms Long-Term Efficacy of Russia's Sputnik V
Sputnik International
International peer-reviewed medical journal Vaccines has published a Russian study proving the efficacy of Russia-made Sputnik V vaccine against COVID-19 in the long-term,
2023-01-10T15:35+0000
2023-01-10T15:35+0000
2023-01-10T15:37+0000
russia
sputnik v vaccine
vaccines
covid-19
antibodies
https://cdn1.img.sputnikglobe.com/img/07e6/0c/15/1105660761_0:167:2784:1733_1920x0_80_0_0_52b03aa6568835eb020d4adbb160e953.jpg
The assessment of Sputnik V's immunogenicity if administered more than once was conducted on 3,983 samples obtained from previously vaccinated individuals aged 20-103. At the same time, over 78% of the vaccinated individuals maintained a level of antibodies sufficient to provide protection against severe cases of the infection. The study revealed that the extent of increase in antibody levels after revaccination depends on the initial level prior to the procedure. Meanwhile, even a single booster dose of the Sputnik Light vaccine, which is essentially the first component of two-component Sputnik V, is sufficient to form immunity in most people regardless of age and preexisting antibody level. Sputnik V is Russia's and the world's pioneer COVID-19 vaccine, registered in August 2020. In addition to the single-dose Sputnik Light version, the original two-dose Sputnik V also has a version for teenagers, Sputnik M. Sputnik V has been approved in 71 countries with a combined population of over 4 billion and Sputnik Light has been approved in more than 30 countries.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2023
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
sputnik v effectiveness, antibodies against covid-19, vaccination, sputnik light, covid-19 pandemic, sputnik v peer-reviewed journal
sputnik v effectiveness, antibodies against covid-19, vaccination, sputnik light, covid-19 pandemic, sputnik v peer-reviewed journal
RDIF: Peer-Reviewed Journal Vaccines Confirms Long-Term Efficacy of Russia's Sputnik V
15:35 GMT 10.01.2023 (Updated: 15:37 GMT 10.01.2023) MOSCOW (Sputnik) - International peer-reviewed medical journal Vaccines has published a Russian study proving the efficacy of Russia-made Sputnik V vaccine against COVID-19 in the long-term, the Russian Direct Investment Fund (RDIF) said on Tuesday.
The assessment of
Sputnik V's immunogenicity if administered more than once was conducted on 3,983 samples obtained from previously vaccinated individuals aged 20-103.
"Sample analysis performed before revaccination of study participants showed that six month after the primary vaccination with Sputnik V, 95.5% of patients maintained a positive level of IgG antibodies to the receptor-binding domain [RBD] of the SARS-Cov-2 virus, which confirms the vaccine’s ability to form a high long-term protection against coronavirus," the RDIF said in a statement.
At the same time, over 78% of the vaccinated individuals maintained a level of antibodies sufficient to provide protection against severe cases of the infection.
The study revealed that the extent of increase in
antibody levels after revaccination depends on the initial level prior to the procedure. Meanwhile, even a single booster dose of the Sputnik Light vaccine, which is essentially the first component of two-component Sputnik V, is sufficient to form immunity in most people regardless of age and preexisting antibody level.
Sputnik V is Russia's and the world's pioneer
COVID-19 vaccine, registered in August 2020. In addition to the single-dose Sputnik Light version, the original two-dose Sputnik V also has a version for teenagers, Sputnik M. Sputnik V has been approved in 71 countries with a combined population of over 4 billion and Sputnik Light has been approved in more than 30 countries.
